Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer

Author： Liu Stephen V   Liu Shanshan   Pinski Jacek  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.6, 2011-06, pp. : 769-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agonists of luteinizing hormone-releasing hormone in prostate cancer

By Rick Ferenc G   Block Norman L   Schally Andrew V  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2237-2247

Informa Healthcare

Access to resources Recommend Favorite

Luteinising hormone-releasing hormone antagonists in prostate cancer therapy

By Msaouel Pavlos   Diamanti Evanthia   Tzanela Marinela   Koutsilieris Michael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 285-299

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)--Agonist Therapy in Prostate Cancer

By Kaisary A.V.   Jarmulowicz M.  

UroOncology, Vol. 3, Iss. 2, 2003-06 ,pp. : 51-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Luteinising hormone releasing hormone analogues in the treatment of prostate cancer

By Gommersall Lyndon M   Hayne Dickon   Shergill Iqbal S   Arya Manit   Wallace DMA  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1685-1692

Informa Healthcare

Access to resources Recommend Favorite

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

By Mongiat-Artus Pierre   Teillac Pierre  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2171-2179

Informa Healthcare

Access to resources Recommend Favorite